Vivani Medical Inc (Vivani Medical) is a biopharmaceutical company focuses on developing miniature, long-term drug implants to address medication non-adherence and tolerability in chronic disease treatment. The company's pipeline products include products include NPM-139 and NPM-115 for obesity and weight management; NPM-133 which treats type 2 diabetes; and OKV-119 which targets canine and feline obesity. It leverages NanoPortal platform technology which is designed to deliver medication steadily. The company operates through its medical centers located across the US. Vivani Medical is headquartered in Alameda, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vivani Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Vivani Medical Inc Company Overview
- Vivani Medical Inc Company Snapshot
- Vivani Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vivani Medical Inc - Pipeline Analysis Overview
- Vivani Medical Inc - Key Facts
- Vivani Medical Inc - Major Products and Services
- Vivani Medical Inc Pipeline Products by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc Pipeline Products Overview
- Argus I Retinal Stimulation System
- Argus I Retinal Stimulation System Product Overview
- Argus III Retinal Stimulation System
- Argus III Retinal Stimulation System Product Overview
- NanoPortal Capsule
- NanoPortal Capsule Product Overview
- NPM-115
- NPM-115 Product Overview
- NPM-115 Clinical Trial
- NPM-119
- NPM-119 Product Overview
- NPM-139
- NPM-139 Product Overview
- NPM-139 Clinical Trial
- Orion Cortical Visual Prosthesis System
- Orion Cortical Visual Prosthesis System Product Overview
- Orion Cortical Visual Prosthesis System Clinical Trial
- Stroke Recovery System
- Stroke Recovery System Product Overview
- Vivani Medical Inc - Key Competitors
- Vivani Medical Inc - Key Employees
- Vivani Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Vivani Medical Inc, Recent Developments
- Jan 29, 2026: Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
- Jan 22, 2026: Vivani Subsidiary Cortigent To Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
- Nov 13, 2025: Vivani Medical Reports Third Quarter 2025 Financial Results
- Oct 22, 2025: Vivani Medical to Present at ThinkEquity Conference
- Sep 24, 2025: Vivani Medical To Present At The Emerging Growth Conference
- Sep 17, 2025: Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
- Sep 17, 2025: Vivani Medical Sets Record Date for Cortigent Spin-off
- Aug 20, 2025: Vivani Medical CEO Adam Mendelsohn To Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
- Jun 10, 2025: Vivani Medical to Present at the 2025 BIO International Convention
- Apr 16, 2025: Vivani Medical To Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Vivani Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vivani Medical Inc Pipeline Products by Equipment Type
- Vivani Medical Inc Pipeline Products by Indication
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc, Key Facts
- Vivani Medical Inc, Major Products and Services
- Vivani Medical Inc Number of Pipeline Products by Development Stage
- Vivani Medical Inc Pipeline Products Summary by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc Ongoing Clinical Trials Summary
- Argus I Retinal Stimulation System - Product Status
- Argus I Retinal Stimulation System - Product Description
- Argus III Retinal Stimulation System - Product Status
- Argus III Retinal Stimulation System - Product Description
- NanoPortal Capsule - Product Status
- NanoPortal Capsule - Product Description
- NPM-115 - Product Status
- NPM-115 - Product Description
- NPM-115 - A Study to Evaluate the Efficacy of NPM-115 for the Treatment of Obesity and Chronic Weight Management
- NPM-119 - Product Status
- NPM-119 - Product Description
- NPM-139 - Product Status
- NPM-139 - Product Description
- NPM-139 - A Randomized, Parallel-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Semaglutide Implant
- Orion Cortical Visual Prosthesis System - Product Status
- Orion Cortical Visual Prosthesis System - Product Description
- Orion Cortical Visual Prosthesis System - A Pivotal Clinical Study of the Orion Cortical Stimulation System to Support Marketing Approval
- Orion Cortical Visual Prosthesis System - Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject
- Stroke Recovery System - Product Status
- Stroke Recovery System - Product Description
- Vivani Medical Inc, Key Employees
- Vivani Medical Inc, Subsidiaries
- Glossary
- Vivani Medical Inc Pipeline Products by Equipment Type
- Vivani Medical Inc Pipeline Products by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- STAAR Surgical Co
- AngioDynamics Inc
- Utah Medical Products Inc
- Iridex Corp
- Dynatronics Corp
